Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine

Area of Science:

• Vaccinology
• Microbiology
• Biotechnology

Background:

• Streptococcus pneumoniae is a major cause of bacterial pneumonia, responsible for over a million deaths annually, particularly in children under five.
• High vaccine costs limit availability in developing nations, contributing to the significant disease burden.
• Current protein polysaccharide conjugate vaccines, like Prevnar13, are effective but involve expensive, multi-step production processes.

Purpose of the Study:

• To design, purify, and produce novel recombinant pneumococcal protein polysaccharide conjugate vaccines using Escherichia coli as a production platform.
• To evaluate the efficacy of these novel recombinant vaccines in a murine model of pneumococcal pneumonia.
• To compare the protective ability of the recombinant vaccines against invasive disease with the efficacy of Prevnar13.

Main Methods:

• Development of recombinant vaccines using Escherichia coli as a host for low-cost production.
• Purification of the novel recombinant protein polysaccharide conjugate vaccines.
• Efficacy testing in a murine model of Streptococcus pneumoniae pneumonia, comparing outcomes to Prevnar13.

Main Results:

• Successful design, purification, and production of novel recombinant pneumococcal protein polysaccharide conjugate vaccines in E. coli.
• Demonstration of vaccine efficacy in a murine model, indicating protection against pneumococcal pneumonia.
• Proof of principle established for E. coli-produced conjugate vaccines preventing pneumococcal infection.

Conclusions:

• Recombinant protein polysaccharide conjugate vaccines produced in E. coli offer a viable, low-cost alternative to current vaccine production methods.
• This approach has the potential to increase vaccine accessibility, particularly in resource-limited settings.
• Further development could lead to more affordable and widely available vaccines against Streptococcus pneumoniae.